Chosen Diagnostics
New Orleans
About Chosen Diagnostics
A biomarker test to diagnose a common and life-threatening bowel disease in preterm infants. It offers more accurate results than current options and allows earlier medical intervention.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.6M
- Last round: Grant (Oct 2021)
- Website: chosendiagnostics.com
- Phone: [email protected]
Industries & Categories
Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/chosen-diagnostics-156978 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.